Occurrence of Ventricular Fibrillation in a Patient With Lung Cancer Receiving Osimertinib

J Thorac Oncol. 2020 Apr;15(4):e54-e55. doi: 10.1016/j.jtho.2019.11.029.

Authors

Kyoichi Kaira¹, Yasufumi Ogiwara², Ichiro Naruse³

Affiliations

¹ Department of Respiratory Medicine, Hidaka Hospital, Gunma, Japan; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan. Electronic address: kkaira1970@yahoo.co.jp.
² Department of Cardiovascular Medicine, Hidaka Hospital, Gunma, Japan.
³ Department of Respiratory Medicine, Hidaka Hospital, Gunma, Japan.

PMID: 32216947
DOI: 10.1016/j.jtho.2019.11.029

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acrylamides
Aniline Compounds
Humans
Lung Neoplasms* / drug therapy
Mutation
Protein Kinase Inhibitors
Ventricular Fibrillation*

Substances

Acrylamides
Aniline Compounds
Protein Kinase Inhibitors
osimertinib